Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2026 19:26 ET | Source: Robbins LLP

TCOM Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Trip.com Group Limited Securities Class Action

Robbins LLP is Investigating Allegations that Trip.com Group Limited (TCOM) Understated the Risk of Regulatory Enforcement in light of its Monopoly
March 17, 2026 19:09 ET | Source: Robbins LLP

Robbins LLP Urges APO Stockholders Who Lost Money Investing in Apollo Global Management, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Apollo Global Management, Inc. (APO) Failed to Disclose to Investors that Jeffrey Epstein was Involved
March 11, 2026 20:19 ET | Source: Robbins LLP

Nektar Therapeutics Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the NKTR Securities Class Action

Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
March 11, 2026 19:13 ET | Source: Robbins LLP

Eos Energy Enterprises, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the EOSE Class Action

Robbins LLP is Investigating Allegations that Eos Energy Enterprises, Inc. (EOSE) Misled Investors Regarding its Business Prospects
February 20, 2026 16:55 ET | Source: Robbins LLP

OST Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Fraud Class Action Against Ostin Technology Group Co., Ltd.

Robbins LLP is Investigating Allegations that Ostin Technology Group Co., Ltd. (OST) Engaged in a Pump-and-Dump Scheme that Defrauded Investors
February 20, 2026 16:38 ET | Source: Robbins LLP

ENPH Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Enphase Energy, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Enphase Energy, Inc. (ENPH) Misled Investors Regarding its Ability to Manage its Channel Inventory
February 18, 2026 14:11 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
February 18, 2026 14:07 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE

Robbins LLP is Investigating Allegations that Ultragenyx Pharmaceutical Inc. (RARE) Misled Investors Regarding Phase III Orbit and Cosmic Studies
February 18, 2026 13:44 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Oracle Corporation Should Contact Robbins LLP for Information About Recovering Their Losses from ORCL

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding its Data Center Capabilities for AI Infrastructure
February 17, 2026 14:29 ET | Source: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects